JoaoA Mde AndradeMD

PubMed

• Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry.
  Joao A de Andrade, Tejaswini Kulkarni, Megan L Neely, Anne S Hellkamp, Amy Hajari Case
  Respiratory Research. 2022-01-07
• 5 citations
  Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry.
  Joao A. de Andrade, Tejaswini Kulkarni, Megan L. Neely, Anne S. Hellkamp, Amy Hajari Case
  Respiratory Medicine. 2021-09-29
• 49 citations
  Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETO...
  Solange Peters, J.-L. Pujol, Urania Dafni, M. Dómine, Sanjay Popat
  Annals of Oncology. 2021-09-23

Journal Articles

• Oxidative Modifications of Protein Tyrosyl Residues are Increased in Plasma of Human Subjects with Interstitial Lung Disease  
  Pennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade J, Thannickal VJ, Am J Respir Crit Care Med, 1/17/2015
• Pleiotropic Effect of the Proton Pump Inhibitor Esomeprazole Leading to Suppression of Lung Inflammation and Fibrosis  
  Ghebremarian YT, Cooke JP, Gerhart W, Griego C, Brower J, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD, J Transl Med, 1/1/2015
• The Idiopathic Pulmonary Fibrosis Clinical Research Network: Diagnostic and Adjudication Processes  
  de Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner R; IPFnet Investigators, Chest, 1/1/2015
• Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis  
  Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi..., N Engl J Med, 1/29/2014
• Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis  
  Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade J, Anstrom KJ, King TE Jr, Raghu G, N Engl J Med, 1/29/2014
• Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core Sets of Domains and Instruments for Use in Clinical Tr...  
  Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Ph..., Thorax, 1/1/2014
• Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Intersti...  
  Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group, J Rheumatol, 1/1/2014
• A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis  
  King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sa..., N Engl J Med, 1/1/2014
• Development and Maintenance of a Biospecimen Repository for Clinical Samples Derived from Pulmonary Patients  
  Schwiebert LM, Estell K, Meadows T, Thannickal VJ, Rowe SM, Sorscher EJ, Harris WT, Gaggar A, Dransfield M, de Andrade J., Clinical and Translational Science, 1/1/2014
• Disparities in Lung Transplantation before and after Introduction of the Lung Allocation Score  
  Wille KM, Harrington KF, de Andrade J, Vishin S, Oster RA, Kaslow RA, J Heart Lung Transplant, 1/1/2013
• Macitentan for the Treatment of Idiopathic Pulmonary Fibrosis: The Randomized Controlled MUSIC Trial  
  Raghu G, Million-Rousseau R, Morganti A, Perchenet L, Behr J; MUSIC Study Group, Eur Respir J, 1/1/2013
• Treatment of Idiopathic Pulmonary Fibrosis with Ambrisentan: A Parallel, Randomized Trial  
  Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, L..., Ann Intern Med, 1/1/2013
• Idiopathic Pulmonary Fibrosis  
  Zolak JS, de Andrade J, Immunol Allergy Clin N Am, 1/1/2012
• A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis  
  Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, et al., Am J Respir Crit Care Med, 1/1/2012
• Prednisone, Azathioprine, and N-acetylcysteine for Pulmonary Fibrosis  
  Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE Jr, Lasky JA, Martinez FJ, N Engl J Med, 1/1/2012
• Acute Exacerbations of Interstitial Lung Disease  
  Hajari AS, de Andrade J, Clinical Pulmonary Medicine, 1/1/2011
• Innovative Approaches to the Therapy of Fibrosis  
  de Andrade J, Thannickal VJ, Current Opinion in Rheumatology, 1/1/2009
• Effect of Interferon Gamma 1b on Survival in Patients with Idiopathic Pulmonary Fibrosis (INSPIRE): A Multicentre, Randomized, Placebo-controlled Trial  
  King TE Jr, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Shan SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM; INSPIRE Study Group, Lancet, 1/1/2009
• BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Patients with Idiopathic Pulmonary Fibrosis  
  King, Jr TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade J, Stahler G, Leconte I, Roux S, Raghu G, American Journal of Respiratory and Critical Care Medicine, 1/1/2008
• Plasma Intercellular Adhesion Molecule-1 and Von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation  
  Covarrubias M, Ware LB, Kawut SM, de Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Wille K, Bellamy S, Shah C, Demissie E, Christie JD, for the Lung Transplant ..., American Journal of Transplantation, 1/1/2007
• Thoughts on the Diagnosis and Management of Interstitial Lung Diseases  
  de Andrade J., Southern Medical Journal, 1/1/2007
• Association of Protein C and Type-1 Plasminogen Activator Inhibitor with Primary Graft Disfunction  
  Christie JD, Robinson N, Ware LB, Plotnick M, de Andrade J, Lama V, Milstone A, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM for the Lung Transplant Outcomes ..., American Journal of Respiratory and Critical Care Medicine, 1/1/2007
• Reactive Nitrogen Species and Myeloperoxidase Correlate with Clinical Markers of Airway Inflammation in Lung Transplant Recipients  
  de Andrade J, Christie JD, Young Jr KR, McGiffin D, Zorn G, Alexander BD, Jackson RM, Journal of Investigative Medicine, 1/1/2001
• Protein Nitration, Metabolites of Reactive Nitrogen Species and Inflammation in Lung Allografts  
  de Andrade J, Crow JP, Viera L, Alexander CB, Young KR, McGiffin DC, Zorn GL, Zhu S, Matalon S, Jackson RM, American Journal of Respiratory and Critical Care Medicine, 1/1/2000
• The Lung in Systemic Lupus Erythematosus  
  de Andrade J, Kennedy JI, Seminars in Respiratory and Critical Care Medicine, 1/1/1999
• Join now to see all

Books/Book Chapters

• Interstitial Lung Disease 
  Chapter: Coagulation and Fibrinolysis in Lung Injury and Repair 
  de Andrade J, Olman MAEditors: Schwarz MI, King TE.People's Medical Publishing House, Shelton, CTEdition 5th,2011
• Cecil Review of Internal Medicine 
  Chapter: Pulmonary Diseases 
  de Andrade JEditors: Cooper JAD, Pappas PG.Elsevier2004
• Cancer-Integracao Clinico-Biologica 
  Chapter: O PDQ (Physician Data Query), um Sistema na Difusao de Formas Correntes e Experimentais para o Tratamento do Câncer 
  Robin H, Vinholes J, Machado V, de Andrade J.Editors: Fleck J.Artes Medicas1992

Abstracts/Posters

• Clinical Characteristics and Disease Burden of Newly Diagnosed IPF at Tertiary Care Centers: Initial Results from the Idiopathic Pulmonary Fibrosis-PROspective Outcome...
  Durheim M, O'Brien E, Gamerman V, Shrader P, Todd JL, Snyder L, Anstrom K, Belperio J, Culver D, de Andrade J, Roman J, Whelan TP, Palmer S, Conoscenti C, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• A Bundle of Care Improves Outcomes in Idiopathic Pulmonary Fibrosis
  Kulkarni T, Acosta Lara P, Willoughby J, Kim Y, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• Next Generation Sequencing Does Not Support a Causative Role for Herpes Virus in IPF
  Lasky J, Yin Q, Flemington E, Zhu D, Kaminski N, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
• Establishing a Standard of Care for Patients with Idiopathic Pulmonary Fibrosis - Concept of "bundle of Care".
  Kulkarni T, Willoughby J, Kim Y, Ramachandran R, Luckhardt T, de Andrade J., Am J Respir Crit Care Med, 1/1/2015
• Short Term Outcomes of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
  Sharma N, Bhatt S, Luckhardt T, de Andrade J., Chest, 1/1/2014
• Safety and Efficacy of Anti-CTGF Monoclonal Antibody Fg-3019 for Treatment of Idiopathic Pulmonary Fibrosis: Results of a Phase 2 Clinical Trials Two Years after Initi...
  Raghu G, Scholand M, de Andrade J, Lancaster L, Mageto YM, Goldin JG, Porter S, Neff TB, Valone F, Stauffer J., Am J Respir Crit Care Med, 1/1/2014
• Therapeutic Targeting If Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis
  Ding Q, Cai GQ, Hu M, Antony VB, Liu G, de Andrade J, Luckhardt T, Liu RM, Zhou Y, Thannickal VJ, Am J Respir Crit Care Med, 1/1/2012
• Testing a Simplified High Resolution CT scan of the Chest (HRCT) Classification as Predictor of Outcomes in Patients with Interstitial Lung Disease
  de Andrade J, Harrington K, Alexander CB, Singh SP, Sanders C, Nath H, American Journal of Respiratory and Critical Care Medicine, 1/1/2010
• Transplant Outcomes in Patients with Connective Tissue Disorders
  Hajari A, Wille K, de Andrade J, Harrington K, Chest, 1/1/2009
• Racial Disparities in Idiopathic Pulmonary Fibrosis: Data from a Southeastern U.S. Center
  de Andrade J, Daniel ND, Wille KM, Gerald LB, Harrington KF, Proceedings of the American Thoracic Society, 1/1/2008
• Combination Therapy Utilizing Azithromycin And Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation
  Hajari A, Leon K, Gaggar A, de Andrade J, Barney J, Pajaro O, George J, Kirklin J, McGiffin D, Young KR, Marques M, Wille K, American College of Chest Physicians, Chest, Chicago, IL, 1/1/2007
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Iloprost Inhalation in Adults with Abnormal Pulmonary Arterial Pressure and...
  Krowka MJ, Ahmad S, de Andrade J, et al., Chest, 1/1/2007
• Donor Gluthatione S-Transferase mu Null Genotype is Independently Associated with Primary Graft Dysfunction Following Lung Transplantation
  Christie JD, Aplenc R, de Andrade J, Lama V, Milstone A, DeMissie E, Ware L, Weinacker A, Kawut, the Lung Transplant Outcomes Group, Proceedings of the American Thoracic Society, 1/1/2006
• Plasma Intercellular Adhesion Molecule-1 (ICAM) and von Willebrand Factor (VWF) in Primary Graft Dysfunction Following Lung Transplantation
  Covarrubias MB, Ware LB, Kawut J, de Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Christie JD, Proceedings of the American Thoracic Society, 1/1/2006
• Donor Glutathione S-Transferase Genotype is Associated with Primary Graft Dysfunction Following Lung Transplantation
  Christie JD, Aplenc R, de Andrade J, Kawut S, Milstone A, Weinacker A, Zhou L, Mazzotta J, DeMissie, Ely EW, Journal of Heart and Lung Transplantation, 1/1/2005
• Early Elevation of Plasma PAI-1 Levels Is Associated with Severe Primary Graft Dysfunction at 72 Hours after Lung Transplantation
  Christie JD, Robinson N, Plotnick M, de Andrade J, Kawut S, Milstone A, Weinacker A, Ware L, for the Lung Transplant Outcomes Group, Proceedings of the American Thoracic Society, 1/1/2005
• Reactive Nitrogen Species, Airway Inflammation and Fibrosis in Lung Transplant
  de Andrade J, Crow J, Viera L, Alexander CB, Young KR, McGiffin D, Zorn G, Matalon S, Jackson R, Chest, 1/1/2001
• Reactive Nitrogen Correlate with Airway Inflammation in Lung Transplants
  de Andrade J, Young KR, McGiffin D, Zorn G, Alexander CB, Christie JD, Jackson R, ALA/ATS International Conference, American Journal of Respiratory and Critical Care Medicine, Toronto, ON, Canada, 1/1/2000
• Reactive Nitrogen Species in Human Allografts and Clinical Correlates
  de Andrade J, Alexander CB, Young KR, McGiffin D, Zorn G, Beckman J, Matalon S, Zhu S, Jackson RM, European Respiratory Society 1999 Annual Congress, European Respiratory Journal, Madrid, Spain, 1/1/1999
• Protein Nitration and Chlorination in Human Lung Allografts
  Jackson R, Ohman T, Helton E, Crow JP, Viera L, Alexander CB, Young KR, McGiffin D, Zorn G, de Andrade J, Beckman J, Matalon S, ALA/ATS International Conference, American Journal of Respiratory and Critical Care Medicine, San Diego, California, 1/1/1999
• Helical Chest Computed Tomography in the Evaluation of Acute Pulmonary Thromboembolism: An Outcome Study
  Ball JA, Inampudi C, de Andrade J, Nath H, Olman MA, ATS/ALA International Conference, American Journal of Respiratory and Critical Care Medicine, Chicago, Illinois, 1/1/1998
• Histological Diagnosis of Bronchogenic Carcinoma. The Role of Sputum Cytology
  Henn LA, de Andrade J, et al., Abstracts of the XXVI Brazilian Congress of Pulmonology. Jornal de Pneumologia, 1/1/1992
• Air Pollution and Public Health. Comparative Study of Two Cities of the Coal Mining Zone of Rio Grande do Sul
  Andrade PP, de Andrade J, Rigatto M, Abstracts of the XXIV Brazilian Congress of Pulmonology. Jornal de Pneumologia, 1/1/1988
• Join now to see all

Lectures

• Idiopathic Pulmonary Fibrosis 
  1/1/2015
• Non-pharmacological management of Idiopathic Pulmonary Fibrosis 
  Montreal, QC, Canada - 1/1/2015
• Clinical Aspects of Other Interstitial Lung Diseases (Non-granulomatous) 
  1/1/2011
• Idiopathic Pulmonary Fibrosis Clinical Trials: Can We Agree on the Endpoints? 
  1/1/2011
• Therapies to Prevent or Treat Acute Exacerbations of Idiopathic Pulmonary Fibrosis 
  1/1/2011
• Acute Exacerbations of ILD and Acute Interstitial Pneumonitis 
  1/1/2010
• Is this Idiopathic Pulmonary Fibrosis? Cases from the Adjudication Committee of the NIH IPFnet 
  1/1/2010
• The Natural History of IPF: What We Have Learned From Clinical Trials 
  1/1/2010
• Clinical Aspects of Idiopathic Pulmonary Fibrosis 
  1/1/2010
• General Approach to Interstitial Lung Diseases - Case Discussion 
  UAB Department of Medicine - 1/1/2010
• Caring for the Patient with Advanced IPF - Review of The (Lack Of) Evidence 
  UAB - 1/1/2009
• Bronchoscopy Should Be Utilized in the Evaluation of the Patient Suspected of Having Acute Exacerbation of Interstitial Disease 
  1/1/2009
• Caring for the Patient with Advanced IPF: Review of the Evidence 
  1/1/2009
• Important Questions in Idiopathic Pulmonary Fibrosis 
  1/1/2008
• Guess Who Is Paying for Lunch: A Critical Look at Our Relationships with the Pharmaceutical Industry 
  1/1/2008
• 42 Years Old Male with Cavitary Lung Lesion 
  1/1/2007
• Who Is Paying for Lunch? A Critical Review of Our Relationships with the Pharmaceutical Industry 
  UAB - 1/1/2007
• Interstitial Lung Diseases related to Connective Tissue Disorders 
  1/1/2007
• General Approach to Interstitial Lung Diseases 
  UAB Department of Medicine - 1/1/2006
• It's a Granuloma! 
  UAB - 1/1/2005
• Overview of Interstitial Lung Diseases 
  UAB Department of Medicine - 1/1/2005
• Update on Idiopathic Pulmonary Fibrosis 
  UAB - 1/1/2004
• Hemodynamic Monitoring 
  UAB Department of Medicine - 1/1/2004
• On Pigs, Stalin, The Spanish Fall of 1918 and the S.A.R.S. Epidemics 
  UAB - 1/1/2003
• Inhalation Lung Diseases and other Disease Processes Producing an Interstitial Pattern on Chest X-Ray 
  University of Alabama School of Medicine - 1/1/2003
• Join now to see all